Molina Healthcare Inc
Set by 24/7 Wall St.’s proprietary analysis of professional targets, profit trajectory, sector, risk, and retail attention. Recalculated at least weekly and after every earnings report.
How we calculate it →Analyst Sentiment
Molina Healthcare faces potential headwinds at current valuations. Our analysis suggests 21.3% downside risk to our $161.03 target. Investors may want to consider reducing exposure or waiting for a better entry point.
The 24/7 Factor
5-Year Projection
Prediction History
| Date | Price Target | Stock Price | Rating | Upside |
|---|---|---|---|---|
| $161.03 | $204.51 | SELL | −21.3% | |
| $166.02 | $209.12 | SELL | −20.6% | |
| $208.20 | $207.42 | HOLD | +0.4% | |
| $201.27 | $197.12 | HOLD | +2.1% | |
| $203.38 | $189.60 | BUY | +7.3% | |
| $204.12 | $190.67 | BUY | +7.1% | |
| $152.00 | $200.79 | SELL | −24.3% | |
| $151.16 | $204.23 | SELL | −26.0% |
Frequently Asked Questions
What is the MOH stock price prediction for 2030?
Looking ahead to 2030, our model projects MOH could trade at an average price of $149.78, with a potential range between $112.33 and $187.22. This represents a potential 26.8% decline from today’s price. Long-term forecasts depend heavily on company execution, competitive dynamics, and broader market conditions.
Is MOH a buy, sell, or hold right now?
24/7 Wall St. currently rates MOH as a SELL. Significant downside (-21.3%) Among Wall Street analysts, 4 rate it Buy, 14 rate it Hold, and 1 rate it Sell.
What is the MOH stock price target in an optimistic scenario?
Our optimistic scenario for MOH projects a price of $193.53 over the next 12 months. Even under favorable conditions, this suggests limited upside from today’s price of $204.51, indicating the stock may currently be trading near or above fair value.
What is the downside risk for MOH stock?
In our conservative scenario, MOH could trade as low as $145.41 over the next 12 months, representing a 28.9% decline from current levels. This scenario accounts for potential headwinds including earnings misses, competitive pressures, or broader market weakness.
Projections are estimates based on current data, updated daily. Not investment advice. Learn how we calculate these projections →